Director
DIN: 07495907
Sachin Sudhir Khardenavis is currently associated with 2 companies in various capacities such as Designated Partner and Individual Promoter. They serve as a Director at LAMISH HEALTHCARE LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07495907.Sachin Sudhir Khardenavis has previously been associated with 1 company in roles such as Director.Sachin Sudhir Khardenavis is currently involved in 2 different roles. Their most recent position is with HEALTHNOVA PHARMA PRIVATE LIMITED as a Individual Promoter. The first company Sachin Sudhir Khardenavis was appointed to was LAMISH HEALTHCARE LLP. Sachin Sudhir Khardenavis is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Sachin Sudhir Khardenavis is currently associated with 2 companies in various capacities such as Designated Partner and Individual Promoter. They serve as a Director at LAMISH HEALTHCARE LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07495907.Sachin Sudhir Khardenavis has previously been associated with 1 company in roles such as Director.Sachin Sudhir Khardenavis is currently involved in 2 different roles. Their most recent position is with HEALTHNOVA PHARMA PRIVATE LIMITED as a Individual Promoter. The first company Sachin Sudhir Khardenavis was appointed to was LAMISH HEALTHCARE LLP. Sachin Sudhir Khardenavis is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (1)
Current LLPs (1)
Past Companies (1)
2y 1m 1y 1m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| HEALTHNOVA PHARMA PRIVATE LIMITED | Individual Promoter | 16-Jul-2020 |